Dirunal Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dirunal group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dirunal Group Today - Breaking & Trending Today

Citrine Medicine Announces Strategic Partnership to bring Efmody® to China for Use in Adrenal Insufficiency (AI), including Congenital Adrenal Hyperplasia (CAH)

Published: May 12, 2021

CAMBRIDGE, Mass. and SHANGHAI, May 12, 2021 /PRNewswire/ Citrine Medicine, a China-based rare disease therapeutics company, today announced that it has signed a licensing agreement with Diurnal Group plc (AIM: DNL), a specialty pharmaceutical company targeting patient needs in chronic endocrine (hormonal) diseases. The deal provides Citrine with exclusive rights to develop and commercialize Efmody
® (hydrocortisone modified-release hard capsules – development name Chronocort
®) in the Greater China market. In January, Citrine signed a licensing agreement with Dirunal Group for Alkindi,
® the first preparation of hydrocortisone specifically designed for use in children suffering from pediatric adrenal insufficiency (AI) and congenital adrenal hyperplasia (CAH). ....

United Kingdom , Melissa Bradford Klug , Finsbury Glover Hering , Dandan Dong , Sarah Sutton , Dirunal Group For Alkindi , European Commission For Efmody , European Medicines Agency , Diurnal Group , Dirunal Group , European Commission , Chief Business Officer , Managing Director , Medical Screening , Congenital Adrenal Hyperplasia , Adrenal Insuffiency , United Kingdom Headquartered , ஒன்றுபட்டது கிஂக்டம் , மெலிசா பிராட்போர்டு க்லக் , ஃபின்ஸ்பரி குளோவர் ஹெர்ரிங் , சாரா சுட்டன் , ஐரோப்பிய தரகு , தலைமை வணிக அதிகாரி , நிர்வகித்தல் இயக்குனர் , மருத்துவ திரையிடல் ,

Citrine Medicine Announces Strategic Partnership to bring Efmody® to China for Use in Adrenal Insufficiency (AI), including Congenital Adrenal Hyperplasia (CAH)

/PRNewswire/ Citrine Medicine, a China-based rare disease therapeutics company, today announced that it has signed a licensing agreement with Diurnal Group. ....

United Kingdom , Melissa Bradford Klug , Finsbury Glover Hering , Dandan Dong , Sarah Sutton , Dirunal Group For Alkindi , European Commission For Efmody , European Medicines Agency , Diurnal Group , Dirunal Group , European Commission , Chief Business Officer , Managing Director , Medical Screening , Congenital Adrenal Hyperplasia , Adrenal Insuffiency , United Kingdom Headquartered , Citrine Medicine , ஒன்றுபட்டது கிஂக்டம் , மெலிசா பிராட்போர்டு க்லக் , ஃபின்ஸ்பரி குளோவர் ஹெர்ரிங் , சாரா சுட்டன் , ஐரோப்பிய தரகு , தலைமை வணிக அதிகாரி , நிர்வகித்தல் இயக்குனர் , மருத்துவ திரையிடல் ,